Definitive Healthcare Corp. (NASDAQ:DH) Position Boosted by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA increased its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 36.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,053,233 shares of the company's stock after acquiring an additional 1,626,813 shares during the period. Massachusetts Financial Services Co. MA owned approximately 5.13% of Definitive Healthcare worth $27,058,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of DH. Intech Investment Management LLC purchased a new position in Definitive Healthcare in the 3rd quarter valued at approximately $55,000. Bleakley Financial Group LLC purchased a new position in shares of Definitive Healthcare in the third quarter valued at $74,000. SG Americas Securities LLC acquired a new position in shares of Definitive Healthcare during the 3rd quarter worth $84,000. Sanctuary Advisors LLC acquired a new position in shares of Definitive Healthcare during the 2nd quarter worth $85,000. Finally, Canada Pension Plan Investment Board acquired a new stake in Definitive Healthcare in the 2nd quarter valued at about $109,000. Hedge funds and other institutional investors own 98.67% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on DH. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a research report on Friday, November 8th. Robert W. Baird cut their price objective on shares of Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Wednesday, August 7th. Stifel Nicolaus decreased their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a "buy" rating on the stock in a research report on Wednesday, July 31st. Morgan Stanley cut their price target on Definitive Healthcare from $9.00 to $5.00 and set an "equal weight" rating for the company in a report on Tuesday, August 6th. Finally, Barclays decreased their price objective on Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Definitive Healthcare presently has a consensus rating of "Hold" and a consensus target price of $5.81.

Definitive Healthcare Stock Performance

Definitive Healthcare stock traded up $0.23 during midday trading on Tuesday, reaching $4.68. 621,767 shares of the stock traded hands, compared to its average volume of 742,754. The firm has a fifty day moving average price of $4.35 and a two-hundred day moving average price of $4.80. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The firm has a market cap of $540.63 million, a price-to-earnings ratio of -1.44, a PEG ratio of 3.22 and a beta of 1.33. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.